Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies
BIO Web of Conferences · 2026 · 240 · 01029
DOI: 10.1051/bioconf/202624001029 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIO Web of Conferences, online erschienen am 24.06.2026. Verfasst von Tingnuo Wang. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
HER2-positive breast cancer is aggressive and associated with poor prognosis worldwide. While passive immunotherapy using monoclonal antibodies is effective, resistance and recurrence remain major challenges. HER2-targeted cancer vaccines offer a promising strategy to induce durable, antigen-specific immune responses. This review summarizes the biological and immunological basis of HER2 targeting, including oncogenic signaling and tumor antigenicity, and outlines both passive and active immunotherapeutic approaches. It highlights advances in HER2 vaccines, particularly mRNA-based strategies, and emphasizes combination therapies with immune checkpoint inhibitors, HER2-targeted agents, chemotherapy, and radiotherapy to enhance antitumor immunity and overcome immune evasion. Despite progress, challenges such as low immunogenicity, HLA restriction, and an immunosuppressive tumor microenvironment limit clinical efficacy. Future directions include optimizing antigen design, expanding combination strategies, and leveraging artificial intelligence for personalized vaccine development. Overall, HER2-targeted vaccines represent a promising frontier in next-generation cancer immunotherapy.
Zitieren
APA
Wang, T. (2026). Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies. BIO Web of Conferences, 240, 01029. https://doi.org/10.1051/bioconf/202624001029
Vancouver
Wang T. Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies. BIO Web of Conferences. 2026;240:01029. doi:10.1051/bioconf/202624001029
BibTeX
@article{Wang2026,
author = {Wang, Tingnuo},
title = {Advances in HER2-Targeted Cancer Vaccines: From Immunological Basis to Next-Generation Therapeutic Strategies},
journal = {BIO Web of Conferences},
year = {2026},
volume = {240},
pages = {01029},
doi = {10.1051/bioconf/202624001029}
}
EUVIMED